J&J expects more than $3 billion in Covid vaccine sales this year in mixed quarterly report

J&J's revenue of $24.8 billion rose 10.8%, mostly driven by $1.82 billion in international sales of its Covid vaccine.

from Earnings https://ift.tt/3qXcY5g
via IFTTT